Skip to main content
Erschienen in: Drug Safety 4/2012

01.04.2012 | Original Research Articles

Assessing Opioid Shopping Behaviour

A Large Cohort Study from a Medication Dispensing Database in the US

verfasst von: Dr M. Soledad Cepeda, Daniel Fife, Wing Chow, Gregory Mastrogiovanni, Scott C. Henderson

Erschienen in: Drug Safety | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Background: Risks of abuse, misuse and diversion of opioids are of concern. Obtaining opioid prescriptions from multiple prescribers, known as opioid shopping, is a way in which opioids may be abused and diverted. Previous studies relied on counting the number of prescribers or number of pharmacies a subject goes to in a year to define shopping behaviour, but did not distinguish successive prescribers from concomitant prescribers.
Objective: The aim of the study was to assess the frequency of opioid overlapping prescriptions from different prescribers, compare it with diuretics and benzodiazepines, and provide a definition of shopping behaviour that differentiates opioids from diuretics, avoiding the inappropriate flagging of individuals with legitimate use of opioids.
Study Design: Population-based cohort study using the IMS LRx database. This database covers 65% of all retail prescriptions in the US and includes mail service and specialty pharmacy provider prescriptions independent of the method of payment.
Setting: Ambulatory.
Patients: Subjects with at least one dispensing for any type of opioid in 2008. Similar cohorts were created for subjects exposed to benzodiazepines or diuretics. Analyses were performed separately for naı¨ve subjects and those with prior use.
Outcome: Frequency of overlapping prescriptions defined as at least 1 day of overlapping dispensing of prescriptions written by two or more different prescribers at any time during an 18-month period.
Results: A total of 25 161 024 subjects exposed to opioids were included, of whom 13.1% exhibited at least one episode of overlapping prescriptions during 18 months of follow-up. Almost 10% of subjects exposed to benzodiazepines and 13.8% of subjects exposed to diuretics exhibited a similar behaviour. Having overlapping prescriptions dispensed by three or more pharmacies differentiates opioids from the other medication classes. Using that criterion, the overall risk of shopping behaviour was 0.18% in subjects exposed to opioids, 0.10% in subjects exposed to benzodiazepines and 0.03% in subjects exposed to diuretics. For opioids, subjects aged between 25 and 64 years exhibited shopping behaviour more commonly (0.25%) than subjects 65 years or older (0.07%), and subjects with a history of prior opioid use exhibited such behaviour more commonly (0.7%) than opioid-naı¨ve subjects (0.07%).
Conclusion: Overlapping of prescriptions is not unique to opioids and therefore a criterion that incorporates number of pharmacies is needed to define shopping behaviour. Having two or more overlapping prescriptions written by different prescribers and filled at three or more pharmacies differentiates opioids from diuretics and likely constitutes shopping behaviour.
Literatur
1.
Zurück zum Zitat Kuehn BM. Opioid prescriptions soar: increase in legitimate use as well as abuse. JAMA 2007; 297 (3): 249–51PubMedCrossRef Kuehn BM. Opioid prescriptions soar: increase in legitimate use as well as abuse. JAMA 2007; 297 (3): 249–51PubMedCrossRef
2.
Zurück zum Zitat Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 2006; 81 (2): 103–7PubMedCrossRef Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 2006; 81 (2): 103–7PubMedCrossRef
3.
Zurück zum Zitat Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008; 300 (22): 2613–20PubMedCrossRef Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008; 300 (22): 2613–20PubMedCrossRef
5.
Zurück zum Zitat Katz N, Panas L, Kim M, et al. Usefulness of prescription monitoring programs for surveillance: analysis of schedule II opioid prescription data in Massachusetts, 1996–2006. Pharmacoepidemiol Drug Saf 2010; 19 (2): 115–23PubMedCrossRef Katz N, Panas L, Kim M, et al. Usefulness of prescription monitoring programs for surveillance: analysis of schedule II opioid prescription data in Massachusetts, 1996–2006. Pharmacoepidemiol Drug Saf 2010; 19 (2): 115–23PubMedCrossRef
6.
Zurück zum Zitat White AG, Birnbaum HG, Schiller M, et al. Analytic models to identify patients at risk for prescription opioid abuse. Am J Manag Care 2009; 15 (12): 897–906PubMed White AG, Birnbaum HG, Schiller M, et al. Analytic models to identify patients at risk for prescription opioid abuse. Am J Manag Care 2009; 15 (12): 897–906PubMed
7.
Zurück zum Zitat Parente ST, Kim SS, Finch MD, et al. Identifying controlled substance patterns of utilization requiring evaluation using administrative claims data.AmJManagCare 2004; 10 (11 Pt 1): 783–90 Parente ST, Kim SS, Finch MD, et al. Identifying controlled substance patterns of utilization requiring evaluation using administrative claims data.AmJManagCare 2004; 10 (11 Pt 1): 783–90
8.
Zurück zum Zitat Sullivan MD, Edlund MJ, Fan MY, et al. Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: the TROUP study. Pain 2010; 150 (2): 332–9PubMedCrossRef Sullivan MD, Edlund MJ, Fan MY, et al. Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: the TROUP study. Pain 2010; 150 (2): 332–9PubMedCrossRef
9.
Zurück zum Zitat Pradel V, Frauger E, Thirion X, et al. Impact of a prescription monitoring program on doctor-shopping for high dosage buprenorphine. Pharmacoepidemiol Drug Saf 2009; 18 (1): 36–43PubMedCrossRef Pradel V, Frauger E, Thirion X, et al. Impact of a prescription monitoring program on doctor-shopping for high dosage buprenorphine. Pharmacoepidemiol Drug Saf 2009; 18 (1): 36–43PubMedCrossRef
10.
Zurück zum Zitat Pradel V, Thirion X, Ronfle E, et al. Assessment of doctorshopping for high dosage buprenorphine maintenance treatment in a French region: development of a new method for prescription database. Pharmacoepidemiol Drug Saf 2004; 13 (7): 473–81PubMedCrossRef Pradel V, Thirion X, Ronfle E, et al. Assessment of doctorshopping for high dosage buprenorphine maintenance treatment in a French region: development of a new method for prescription database. Pharmacoepidemiol Drug Saf 2004; 13 (7): 473–81PubMedCrossRef
11.
Zurück zum Zitat Baehren DF, Marco CA, Droz DE, et al. A statewide prescription monitoring program affects emergency department prescribing behaviors. Ann Emerg Med 2010; 56 (1): 19–23PubMedCrossRef Baehren DF, Marco CA, Droz DE, et al. A statewide prescription monitoring program affects emergency department prescribing behaviors. Ann Emerg Med 2010; 56 (1): 19–23PubMedCrossRef
12.
Zurück zum Zitat Pauly V, Frauger E, Pradel V, et al. Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures? Controlling high dosage buprenorphine abuse. Drug Alcohol Depend 2011; 113 (1): 29–36PubMedCrossRef Pauly V, Frauger E, Pradel V, et al. Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures? Controlling high dosage buprenorphine abuse. Drug Alcohol Depend 2011; 113 (1): 29–36PubMedCrossRef
13.
Zurück zum Zitat Butler SF, Black RA, Serrano JM, et al. Characteristics of prescription opioid abusers in treatment: prescription opioid use history, age, use patterns, and functional severity. J Opioid Manag 2010; 6 (4): 239–52PubMedCrossRef Butler SF, Black RA, Serrano JM, et al. Characteristics of prescription opioid abusers in treatment: prescription opioid use history, age, use patterns, and functional severity. J Opioid Manag 2010; 6 (4): 239–52PubMedCrossRef
14.
Zurück zum Zitat Edlund MJ, Steffick D, Hudson T, et al. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain 2007; 129 (3): 355–62PubMedCrossRef Edlund MJ, Steffick D, Hudson T, et al. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain 2007; 129 (3): 355–62PubMedCrossRef
Metadaten
Titel
Assessing Opioid Shopping Behaviour
A Large Cohort Study from a Medication Dispensing Database in the US
verfasst von
Dr M. Soledad Cepeda
Daniel Fife
Wing Chow
Gregory Mastrogiovanni
Scott C. Henderson
Publikationsdatum
01.04.2012
Verlag
Springer International Publishing
Erschienen in
Drug Safety / Ausgabe 4/2012
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI
https://doi.org/10.2165/11596600-000000000-00000

Weitere Artikel der Ausgabe 4/2012

Drug Safety 4/2012 Zur Ausgabe

Review Article

Safety of Flecainide